Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH – Get Free Report) saw strong trading volume on Tuesday . 155,981 shares were traded during mid-day trading, a decline of 10% from the previous session’s volume of 172,754 shares.The stock last traded at $5.51 and had previously closed at $5.44.
Analysts Set New Price Targets
A number of equities research analysts have weighed in on the stock. Royal Bank of Canada upped their price objective on shares of Aveanna Healthcare from $3.00 to $5.00 and gave the stock a “sector perform” rating in a report on Friday, August 9th. Deutsche Bank Aktiengesellschaft upped their target price on shares of Aveanna Healthcare from $3.00 to $5.00 and gave the stock a “buy” rating in a research note on Friday, August 9th. Finally, UBS Group upped their target price on shares of Aveanna Healthcare from $1.70 to $2.80 and gave the stock a “sell” rating in a research note on Friday, August 9th.
Get Our Latest Research Report on Aveanna Healthcare
Aveanna Healthcare Price Performance
Aveanna Healthcare (NASDAQ:AVAH – Get Free Report) last issued its quarterly earnings data on Thursday, August 8th. The company reported ($0.01) EPS for the quarter, topping analysts’ consensus estimates of ($0.04) by $0.03. The business had revenue of $504.96 million during the quarter, compared to analysts’ expectations of $494.02 million. On average, analysts predict that Aveanna Healthcare Holdings Inc. will post -0.09 EPS for the current year.
Hedge Funds Weigh In On Aveanna Healthcare
Several hedge funds and other institutional investors have recently modified their holdings of AVAH. Bank of New York Mellon Corp lifted its holdings in Aveanna Healthcare by 6.6% in the 2nd quarter. Bank of New York Mellon Corp now owns 149,761 shares of the company’s stock valued at $413,000 after purchasing an additional 9,243 shares in the last quarter. Mackenzie Financial Corp lifted its position in shares of Aveanna Healthcare by 35.9% during the 2nd quarter. Mackenzie Financial Corp now owns 45,674 shares of the company’s stock worth $126,000 after purchasing an additional 12,075 shares during the last quarter. Acadian Asset Management LLC boosted its position in shares of Aveanna Healthcare by 185.6% during the 1st quarter. Acadian Asset Management LLC now owns 29,385 shares of the company’s stock worth $72,000 after acquiring an additional 19,096 shares in the last quarter. Vanguard Group Inc. increased its stake in Aveanna Healthcare by 1.8% in the first quarter. Vanguard Group Inc. now owns 2,571,251 shares of the company’s stock valued at $6,402,000 after purchasing an additional 44,970 shares during the last quarter. Finally, Renaissance Technologies LLC lifted its position in Aveanna Healthcare by 155.8% in the second quarter. Renaissance Technologies LLC now owns 158,600 shares of the company’s stock valued at $438,000 after acquiring an additional 96,600 shares during the last quarter. 87.96% of the stock is owned by hedge funds and other institutional investors.
Aveanna Healthcare Company Profile
Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.
Read More
- Five stocks we like better than Aveanna Healthcare
- What Are Trending Stocks? Trending Stocks Explained
- Biohaven Stock Soars on Drug Trial Results: Time to Jump In?
- What Is WallStreetBets and What Stocks Are They Targeting?
- Is AMD a Legitimate Threat to NVIDIA? What Investors Should Watch
- ESG Stocks, What Investors Should Know
- Novo Nordisk’s Setback Won’t Last: A Game-Changing Drug Emerges
Receive News & Ratings for Aveanna Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aveanna Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.